<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Journal of Modern Oncology</journal-id><journal-title-group><journal-title xml:lang="en">Journal of Modern Oncology</journal-title><trans-title-group xml:lang="ru"><trans-title>Современная онкология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1815-1434</issn><issn publication-format="electronic">1815-1442</issn><publisher><publisher-name xml:lang="en">LLC Obyedinennaya Redaktsiya</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">26602</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Nekhodzhkinskie limfomy marginal'noy zony</article-title><trans-title-group xml:lang="ru"><trans-title>Неходжкинские лимфомы маргинальной зоны</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Poddubnaya</surname><given-names>I V</given-names></name><name xml:lang="ru"><surname>Поддубная</surname><given-names>И В</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра онкологии</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Moskalenko</surname><given-names>O A</given-names></name><name xml:lang="ru"><surname>Москаленко</surname><given-names>О А</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра онкологии</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Balakireva</surname><given-names>Yu N</given-names></name><name xml:lang="ru"><surname>Балакирева</surname><given-names>Ю Н</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра онкологии</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">РМАПО, Москва</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2006-03-15" publication-format="electronic"><day>15</day><month>03</month><year>2006</year></pub-date><volume>8</volume><issue>1</issue><issue-title xml:lang="en">VOL 8, NO1 (2006)</issue-title><issue-title xml:lang="ru">ТОМ 8, №1 (2006)</issue-title><fpage>8</fpage><lpage>12</lpage><history><date date-type="received" iso-8601-date="2020-04-09"><day>09</day><month>04</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2006, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2006, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2006</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://modernonco.orscience.ru/1815-1434/article/view/26602">https://modernonco.orscience.ru/1815-1434/article/view/26602</self-uri><abstract xml:lang="ru"><p>Неходжкинские лимфомы (НХЛ) - это злокачественные опухоли с быстрым ростом заболеваемости во всем мире. Заболеваемость НХЛ значительно выше в развитых странах (увеличилась более чем на 50% за последние 20 лет). Темп прироста заболеваемости НХЛ превышает таковой при лимфоме Ходжкина. Одним из вариантов индолентных НХЛ являются лимфомы маргинальной зоны. В настоящее время установлено, что лимфомы маргинальной зоны возникают из клеток, являющихся опухолевым эквивалентом нормальных клеток маргинальной зоны, обнаруживаемых в лимфоидной ткани селезенки, слизистых оболочек (MALT) и, в меньшей степени, лимфатических узлах. Характерной особенностью нормальных клеток маргинальной зоны является их способность пролиферировать в ответ на тимуснезависимые и тимусзависимые антигены и отсутствие рециркуляции.</p></abstract><kwd-group xml:lang="ru"><kwd>злокачественные опухоли</kwd><kwd>лимфома</kwd><kwd>маргинальная зона</kwd><kwd>MALT-лимфома</kwd><kwd>лимфатический узел</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Hyjek E, Isaacsjn P. Hum Pathol 1988; 19: 1315-26.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Isaacson P. Ann Oncol 1995; 319-20.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Armitage J.O, Weisenburger D.D.J. Clin Oncol J 1998; 16: 2780-95.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Thieblemont C, Berger F, Dumontet C et al. Blood 2000; 95: 802-6.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Wotherspoon A.C, Doglioni C, Isaacson P.G. Histopathology 1992; 20: 29.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Bernard S.M, Cartwright R.A, Bird C.C et al. Leuk Res 1984; 8: 681.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Gospodarowicz M, Bush R, Brown T et al. Int J Radiat Oncol Biol Phys 1983; 9: 3-9.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Gospodarowicz M, Sutcliffe S.B, Clark R.M et al. Int J Radiat Oncol Biol Phys 1990; 19: 1351-5.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Gospodarowicz M, Pintille M, Tsang R et al. Recent Result Cancer Res 2000; 156: 108-15.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Thirlby R.C. Oncology 1993; 7: 29-32.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Sano T. Recent Results Cancer Res 2000; 156: 104-7.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Maor M.H, Velasquez W.S, Fuller L.M et al. J Clin Oncolog 1990; 8: 266.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Montalban C, Santon A, Redondo C et al. An Oncology 2005; 16 (9): 1539-45.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Zucca E, Conconi A, Gospodarowicz M, Cavalli F et al. Blood 2002; 94: 4214-21.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Conconi A, Martinelli G, Thieblemont C, Ferreri A.J et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 2003 Oct 15; 102 (8): 2741-5. Epub 2003 Jul 3.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Khojasteh A, Haghshenass M. N Engl J Med 1983; 308: 1401.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Price S.K. Histopathology 1990; 17: 7-17.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Ben Ayed F, Halphen M, Najjar T et al. Cancer 1989; 63: 1251-6.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Isaacson P.G, Matutes E, Burke M et al. Am J Surg Pathol 1989; 13: 1023-33.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Isaacson P.G, Hum Pathol 1994; 25: 1020-9.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Salem P.A, Nassas V.H, Shahid M.J et al. Cancer 1977; 40: 2941.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Peng H. An Oncol 1999; 10 (suppl. 3): abs. 018.</mixed-citation></ref></ref-list></back></article>
